Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Iron deposition in the precentral grey matter in patients with multiple sclerosis: A quantitative study using susceptibility-weighted imaging.
Purine-crosslinked injectable chitosan sponges promote oligodendrocyte progenitor cells' attachment and differentiation.
Dimethyl Fumarate: A Review in Relapsing-Remitting MS.
[A retrospective study of patients with early onset of multiple sclerosis in Omskaya Oblast.]
Exacerbation of Experimental Autoimmune Encephalomyelitis in the Absence of Breast Regression Protein 39/Chitinase 3-Like 1.
Does Aquaporin-4-Seronegative Neuromyelitis Optica Exist?
Free radicals: properties, sources, targets, and their implication in various diseases.
Early CNS neurodegeneration in radiologically isolated syndrome.
Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
Transglutaminase 2 and neuroinflammation.
Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci.
4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review.
Multiple Sclerosis: Current Knowledge and Future Outlook.
[Intrathecal immunoglobulin production in the diagnosis and differential diagnosis of multiple sclerosis.]
NLRP3 Inflammasome and MS/EAE.
Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies.
Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses.
Myocarditis and diffuse skeletal muscle oedema: new features of neuromyelitis optica spectrum disorder? A case report.
Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders.
Reliability of Longitudinal Brain Volume Loss Measurements between 2 Sites in Patients with Multiple Sclerosis: Comparison of 7 Quantification Techniques.
Ion Channels in Neurological Disorders.
Disease-modifying therapies and infectious risks in multiple sclerosis.
The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis.
An initial validation of the Italian Mishel Uncertainty Illness Scale (MUIS) for relapsing remitting multiple sclerosis patients.
Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study.

Pages